These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 23469136)
41. Kinetics of calcium release by immunoaffinity-purified inositol 1,4,5-trisphosphate receptor in reconstituted lipid vesicles. Hirota J; Michikawa T; Miyawaki A; Furuichi T; Okura I; Mikoshiba K J Biol Chem; 1995 Aug; 270(32):19046-51. PubMed ID: 7642567 [TBL] [Abstract][Full Text] [Related]
42. Synthesis of dimeric analogs of adenophostin A that potently evoke Ca Vibhute AM; Pushpanandan P; Varghese M; Koniecnzy V; Taylor CW; Sureshan KM RSC Adv; 2016 Nov; 6(89):86346-86351. PubMed ID: 28066549 [TBL] [Abstract][Full Text] [Related]
43. Activation of IP3 receptors requires an endogenous 1-8-14 calmodulin-binding motif. Sun Y; Rossi AM; Rahman T; Taylor CW Biochem J; 2013 Jan; 449(1):39-49. PubMed ID: 23009366 [TBL] [Abstract][Full Text] [Related]
45. Thimerosal stimulates Ca2+ flux through inositol 1,4,5-trisphosphate receptor type 1, but not type 3, via modulation of an isoform-specific Ca2+-dependent intramolecular interaction. Bultynck G; Szlufcik K; Kasri NN; Assefa Z; Callewaert G; Missiaen L; Parys JB; De Smedt H Biochem J; 2004 Jul; 381(Pt 1):87-96. PubMed ID: 15015936 [TBL] [Abstract][Full Text] [Related]
46. Functional determination of calcium-binding sites required for the activation of inositol 1,4,5-trisphosphate receptors. Arige V; Terry LE; Wagner LE; Malik S; Baker MR; Fan G; Joseph SK; Serysheva II; Yule DI Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2209267119. PubMed ID: 36122240 [TBL] [Abstract][Full Text] [Related]
47. Determinants of adenophostin A binding to inositol trisphosphate receptors. Morris SA; Nerou EP; Riley AM; Potter BV; Taylor CW Biochem J; 2002 Oct; 367(Pt 1):113-20. PubMed ID: 12088506 [TBL] [Abstract][Full Text] [Related]
48. Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. Yoshikawa F; Morita M; Monkawa T; Michikawa T; Furuichi T; Mikoshiba K J Biol Chem; 1996 Jul; 271(30):18277-84. PubMed ID: 8663526 [TBL] [Abstract][Full Text] [Related]
49. Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. Blondel O; Takeda J; Janssen H; Seino S; Bell GI J Biol Chem; 1993 May; 268(15):11356-63. PubMed ID: 8388391 [TBL] [Abstract][Full Text] [Related]
50. IP3 receptors: Take four IP3 to open. Taylor CW; Konieczny V Sci Signal; 2016 Apr; 9(422):pe1. PubMed ID: 27048564 [TBL] [Abstract][Full Text] [Related]
51. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors. Marchant JS; Beecroft MD; Riley AM; Jenkins DJ; Marwood RD; Taylor CW; Potter BV Biochemistry; 1997 Oct; 36(42):12780-90. PubMed ID: 9335535 [TBL] [Abstract][Full Text] [Related]
52. Inositol 1,4,5-trisphosphate [correction of tris-phosphate] activation of inositol trisphosphate [correction of tris-phosphate] receptor Ca2+ channel by ligand tuning of Ca2+ inhibition. Mak DO; McBride S; Foskett JK Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15821-5. PubMed ID: 9861054 [TBL] [Abstract][Full Text] [Related]
54. Adenophostin A and inositol 1,4,5-trisphosphate differentially activate Cl- currents in Xenopus oocytes because of disparate Ca2+ release kinetics. Machaca K; Hartzell HC J Biol Chem; 1999 Feb; 274(8):4824-31. PubMed ID: 9988722 [TBL] [Abstract][Full Text] [Related]
55. Adenophostin A and ribophostin, but not inositol 1,4,5-trisphosphate or manno-adenophostin, activate the Ca2+ release-activated Ca2+ current, I(CRAC), in weak intracellular Ca2+ buffer. Parekh AB; Riley AM; Potter BV Biochem J; 2002 Jan; 361(Pt 1):133-41. PubMed ID: 11742538 [TBL] [Abstract][Full Text] [Related]
56. Synthesis of adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligands. Mochizuki T; Kondo Y; Abe H; Tovey SC; Dedos SG; Taylor CW; Paul M; Potter BV; Matsuda A; Shuto S J Med Chem; 2006 Sep; 49(19):5750-8. PubMed ID: 16970399 [TBL] [Abstract][Full Text] [Related]
57. Disease-associated mutations in inositol 1,4,5-trisphosphate receptor subunits impair channel function. Terry LE; Alzayady KJ; Wahl AM; Malik S; Yule DI J Biol Chem; 2020 Dec; 295(52):18160-18178. PubMed ID: 33093175 [TBL] [Abstract][Full Text] [Related]
58. Guanophostin A: Synthesis and evaluation of a high affinity agonist of the D-myo-inositol 1,4,5-trisphosphate receptor. Sureshan KM; Trusselle M; Tovey SC; Taylor CW; Potter BV Chem Commun (Camb); 2006 May; (19):2015-7. PubMed ID: 16767260 [TBL] [Abstract][Full Text] [Related]
59. Modulation of inositol 1,4,5-trisphosphate binding to the recombinant ligand-binding site of the type-1 inositol 1,4, 5-trisphosphate receptor by Ca2+ and calmodulin. Sipma H; De Smet P; Sienaert I; Vanlingen S; Missiaen L; Parys JB; De Smedt H J Biol Chem; 1999 Apr; 274(17):12157-62. PubMed ID: 10207043 [TBL] [Abstract][Full Text] [Related]
60. Region-specific proteolysis differentially modulates type 2 and type 3 inositol 1,4,5-trisphosphate receptor activity in models of acute pancreatitis. Wang L; Wagner LE; Alzayady KJ; Yule DI J Biol Chem; 2018 Aug; 293(34):13112-13124. PubMed ID: 29970616 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]